Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials (Q31108441)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials |
scientific article |
Statements
1 reference
Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials (English)
1 reference
Bonaventura Clotet
1 reference
Jean-Michel Molina
1 reference
David Cooper
1 reference
Nicholas Bellos
1 reference
Andrej Wöhrmann
1 reference
Timothy Wilkin
1 reference
Richard Haubrich
1 reference
Calvin Cohen
1 reference
Charles Farthing
1 reference
Dushyantha Jayaweera
1 reference
Martin Markowitz
1 reference
Peter Ruane
1 reference
Sabrina Spinosa-Guzman
1 reference
Eric Lefebvre
1 reference
POWER 1 and 2 study groups
1 reference
Identifiers
1 reference